A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

INTRODUCTION: Exenatide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), approved for treatment of type 2 diabetes mellitus (T2DM). There is limited direct evidence comparing the efficacy and tolerability of exenatide 2 mg once weekly (QW) to other GLP-1 RAs. A network meta-analysis (NMA) w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Ther
Main Authors: Kayaniyil, Sheena, Lozano-Ortega, Greta, Bennett, Heather A., Johnsson, Kristina, Shaunik, Alka, Grandy, Susan, Kartman, Bernt
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2016
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801811/
https://ncbi.nlm.nih.gov/pubmed/26886440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0155-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki